Annexin A1: a key regulator of T cell function and bone marrow adiposity in aplastic anaemia
The Journal of Physiology · 2024-11 · 602 (22) · 6125-6152
DOI: 10.1113/jp286148 ↗At a glance
Journal article in The Journal of Physiology, published online on 2024-10-07. Written by Xia Liu and 6 co-authors. Institution: Department of Respiratory Intervention, Children's Hospital Affiliated to Shandong University, Jinan, China. Major MEDLINE topics: Anemia, Aplastic, Annexin A1, Bone Marrow, Adiposity. Cited 4 times so far (Crossref); 72 references. Funded by: SDU-KI Collaborative Research Project of Qilu Medical College, Shandong University, the Natural Science Foundation of Shandong Province.
Abstract (original language)
This study investigates the role of Annexin A1 (ANXA1) in regulating T cell function and its implications in bone marrow adiposity in aplastic anaemia (AA). Utilizing single‐cell sequencing analysis, we compared bone marrow tissues from AA patients and healthy individuals, focusing on T cell subgroups and their impact on bone marrow pathology. Our findings reveal a significant activation of CD8 + T cells in AA, driven by reduced ANXA1 expression. This heightened T cell activity promotes adipogenesis in bone marrow‐derived mesenchymal stem cells via IFN‐γ secretion. Overexpression of ANXA1 was found to suppress this process, suggesting its therapeutic potential in AA treatment. The study highlights ANXA1 as a crucial regulator in the AA‐associated immune microenvironment and bone marrow adiposity. image Key points This study found that ANXA1 is significantly downregulated in AA and provides detailed insights into its critical role in the disease. The study demonstrates the excessive activation of CD8 + T cells in the progression of AA. The research shows that the overexpression of ANXA1 can effectively inhibit the activation of CD8 + T cells. The study confirms that overexpression of ANXA1 reduces the secretion of the cytokine IFN‐γ, decreases adipogenesis in bone marrow‐derived mesenchymal stem cells and may improve AA symptoms. This research provides new molecular targets for the treatment of AA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Respiratory Intervention, Children's Hospital Affiliated to Shandong University, Jinan, China.
- Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- JiNan Key Laboratory of Basic and Clinical Translational Research in Radiobiology, Jinan, China.
- Department of Hematology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Pathology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Institute of Biotherapy for Hematological Malignancies, Shandong University, Jinan, China.
ORCID profiles: Dexiao Kong
Funding
- SDU-KI Collaborative Research Project of Qilu Medical College, Shandong University
- the Natural Science Foundation of Shandong Province
Cite
APA
Liu, X., Li, X., Li, H., Guan, B., Jiang, Y., Zheng, C., & Kong, D. (2024). Annexin A1: a key regulator of T cell function and bone marrow adiposity in aplastic anaemia. The Journal of Physiology, 602(22), 6125-6152. https://doi.org/10.1113/jp286148
Vancouver
Liu X, Li X, Li H, Guan B, Jiang Y, Zheng C, et al. Annexin A1: a key regulator of T cell function and bone marrow adiposity in aplastic anaemia. The Journal of Physiology. 2024;602(22):6125-6152. doi:10.1113/jp286148
BibTeX
@article{Liu2024,
author = {Liu, Xia and Li, Xiaomei and Li, Hui and Guan, Bingxin and Jiang, Yang and Zheng, Chengyun and Kong, Dexiao},
title = {Annexin A1: a key regulator of T cell function and bone marrow adiposity in aplastic anaemia},
journal = {The Journal of Physiology},
year = {2024},
volume = {602},
number = {22},
pages = {6125--6152},
doi = {10.1113/jp286148}
}
EUVIMED